Impact of hyperglycemia on neuropathological alterations during critical illness

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages 2113-2123

  Sonneville, Romain ^a,b,c   Den Hertog, Heleen M ^a,d   Güiza, Fabian ^a   Gunst, Jan ^a   Derese, Inge ^a   Wouters, Pieter J ^a   Brouland, Jean Philippe ^e   Polito, Andrea ^b   Gray, Françoise ^e   Chrétien, Fabrice ^c,f   Charlier, Philippe ^b,c   Annane, Djillali ^b,c   Sharshar, Tarek ^b,c   Van Den Berghe, Greet ^a   Vanhorebeek, Ilse ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e HÔPITAL LARIBOISIÈRE   (France)

^f INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MALE; MICROGLIA; MORTALITY; NERVE CELL; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUDDEN DEATH;

ADULT; AGED; ANIMALS; BLOOD GLUCOSE; BRAIN DISEASES; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICROGLIA; MIDDLE AGED; RABBITS; RISK FACTORS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84861963475     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2971     Document Type: Article

References (44)

1. Vanhorebeek I, Langouche L, Van den Berghe G 2007 Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 132:268-278 (Pubitemid 47068231)
2. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G 2010 Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 38:1021-1029
3. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
4. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461 (Pubitemid 43200296)
5. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G 2009 Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373:547-556
6. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G 2007 Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175:480-489 (Pubitemid 46354252)
7. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ 2005 Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348-1353 (Pubitemid 40570499)
8. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ 2009 Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
9. Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D 2009 Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 94:3163-3170
10. Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santré C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec'h C, Mayaux J, Lejeune J, Chevret S 2010 Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303:341-348
11. Boord JB, Graber AL, Christman JW, Powers AC 2001 Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med 164:1763-1767 (Pubitemid 33152307)
12. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA 2007 Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117:910-918 (Pubitemid 46556747)
13. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, Glenn T, Martin N, Hovda D 2006 Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 34:850-856
14. Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le Roux P, Mayer SA 2008 Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 36:3233-3238
15. Auer RN 2004 Hypoglycemic brain damage. Metab Brain Dis 19:169-175 (Pubitemid 39361179)
16. Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, Orlikowski D, Raphael JC, Gajdos P, Annane D 2003 Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362:1799-1805 (Pubitemid 37494758)
17. Slaoui M, Fiette L 2011 Histopathology procedures: from tissue sampling to histopathological evaluation. Methods Mol Biol 691:69-82
18. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G 2006 Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55:1096-1105 (Pubitemid 44100187)
19. Vanhorebeek I, Gunst J, Ellger B, Boussemaere M, Lerut E, Debaveye Y, Rabbani N, Thornalley PJ, Schetz M, Van den Berghe G 2009 Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney Int 76:512-520
20. Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C, Van den Berghe G 2003 Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144:5329-5338 (Pubitemid 37476061)
21. da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannotta FS, Vitkovic L 1993 Gliosis in human brain: relationship to size but not other properties of astrocytes. Brain Res 600:161-165 (Pubitemid 23034266)
22. Lebed YV, Orlovsky MA, Nikonenko AG, Ushakova GA, Skibo GG 2008 Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes. Neurosci Lett 444:181-185
23. Lemstra AW, Groen in't Woud JC, Hoozemans JJ, van Haastert ES, Rozemuller AJ, Eikelenboom P, van Gool WA 2007 Microglia activation in sepsis: a case-control study. J Neuroinflammation 4:4
24. Streit WJ, Kreutzberg GW 1987 Lectin binding by resting and reactive microglia. J Neurocytol 16:249-260 (Pubitemid 17080832)
25. Nakase T, Yoshida Y, Nagata K 2006 Enhanced connexin 43 immunoreactivity in penumbral areas in the human brain following ischemia. Glia 54:369-375 (Pubitemid 44422939)
26. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Françoise G 2004 The neuropathology of septic shock. Brain Pathol 14:21-33 (Pubitemid 38200586)
27. Kodl CT, Franc DT, Rao JP, Anderson FS, Thomas W, Mueller BA, Lim KO, Seaquist ER 2008 Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 57:3083-3089
28. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM 2006 Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326-333 (Pubitemid 43343260)
29. van Elderen SG, de Roos A, de Craen AJ, Westendorp RG, Blauw GJ, Jukema JW, Bollen EL, Middelkoop HA, van Buchem MA, van der Grond J 2010 Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 75:997-1002
30. Lechuga-Sancho AM, Arroba AI, Frago LM, Pañeda C, García- Cáceres C, Delgado Rubín de Célix A, Argente J, Chowen JA 2006 Activation of the intrinsic cell death pathway, increased apoptosis and modulation of astrocytes in the cerebellum of diabetic rats. Neurobiol Dis 23:290-299 (Pubitemid 44080840)
31. Muranyi M, Ding C, He Q, Lin Y, Li PA 2006 Streptozotocin-induced diabetes causes astrocyte death after ischemia and reperfusion injury. Diabetes 55:349-355 (Pubitemid 43343263)
32. Coleman ES, Dennis JC, Braden TD, Judd RL, Posner P 2010 Insulin treatment prevents diabetes-induced alterations in astrocyte glutamate uptake and GFAP content in rats at 4 and 8 weeks of diabetes duration. Brain Res 1306:131-141
33. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW 2005 Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559-1565 (Pubitemid 40586690)
34. Lechuga-Sancho AM, Arroba AI, Frago LM, García-Cáceres C, de Célix AD, Argente J, Chowen JA 2006 Reduction in the number of astrocytes and their projections is associated with increased synaptic protein density in the hypothalamus of poorly controlled diabetic rats. Endocrinology 147:5314-1424
35. Kondo F, Asanuma M, Miyazaki I, Kondo Y, Tanaka K, Makino H, Ogawa N 2001 Progressive cortical atrophy after forebrain ischemia in diabetic rats. Neurosci Res 39:339-346 (Pubitemid 32186386)
36. Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L, Diamond DM 2008 Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 9:531-539
37. Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J 2007 Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842-1852 (Pubitemid 46698465)
38. Iwashyna TJ, Ely EW, Smith DM, Langa KM 2010 Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787-1794
39. van Gool WA, van de Beek D, Eikelenboom P 2010 Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 375:773-775
40. Dringen R 2005 Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 7:1223-1233 (Pubitemid 41232519)
41. Arnal E, Miranda M, Barcia J, Bosch-Morell F, Romero FJ 2010 Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. Neuroscience 166:271-278
42. Edwards JL, Vincent AM, Cheng HT, Feldman EL 2008 Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1-34
43. Langouche L, Vander Perre S, Wouters PJ, D'Hoore A, Hansen TK, Van den Berghe G 2007 Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 92:3890-3897 (Pubitemid 47607638)
44. Langouche L, Meersseman W, Vander Perre S, Milants I, Wouters PJ, Hermans G, Gjedsted J, Hansen TK, Arnout J, Wilmer A, Schetz M, Van den Berghe G 2008 Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med 36:1475-1480 (Pubitemid 351620651)